Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PRQR

ProQR Therapeutics

$17.82

-0.22 (-1.22%)

11:55
12/17/18
12/17
11:55
12/17/18
11:55
Hot Stocks
ProQR Therapeutics announces publication of QR-110 data in Nature Medicine »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Thursday
PRQR

ProQR Therapeutics

$18.55

1.41 (8.23%)

, NITE

Nightstar Therapeutics

$12.05

-0.32 (-2.59%)

07:21
12/13/18
12/13
07:21
12/13/18
07:21
Hot Stocks
ProQR Therapeutics announces changes to management team, names Aniz Girach CMO »

ProQR (PRQR) Therapeutics…

PRQR

ProQR Therapeutics

$18.55

1.41 (8.23%)

NITE

Nightstar Therapeutics

$12.05

-0.32 (-2.59%)

GILD

Gilead

$67.57

0.39 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
PRQR

ProQR Therapeutics

$18.00

-0.16 (-0.88%)

07:12
12/10/18
12/10
07:12
12/10/18
07:12
Hot Stocks
ProQR Therapeutics receives EUR4.7M credit from Dutch government for QR-110 »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$19.16

0.17 (0.90%)

07:04
12/04/18
12/04
07:04
12/04/18
07:04
Hot Stocks
ProQR Therapeutics announces FDA clearance of QR-421a IND »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYGR

Voyager Therapeutics

$11.67

0.44 (3.92%)

, JAZZ

Jazz Pharmaceuticals

$146.22

-3.81 (-2.54%)

04:55
11/29/18
11/29
04:55
11/29/18
04:55
Conference/Events
Evercore ISI to hold a conference »

Evercore ISI HEALTHConx…

VYGR

Voyager Therapeutics

$11.67

0.44 (3.92%)

JAZZ

Jazz Pharmaceuticals

$146.22

-3.81 (-2.54%)

ALXN

Alexion

$122.91

2.01 (1.66%)

IMGN

ImmunoGen

$5.63

0.37 (7.03%)

DOVA

Dova Pharmaceuticals

$15.29

0.16 (1.06%)

PRQR

ProQR Therapeutics

$19.00

-0.06 (-0.31%)

HRTX

Heron Therapeutics

$28.40

1.95 (7.37%)

BOLD

Audentes Therapeutics

$24.30

0.81 (3.45%)

CDNA

CareDx

$28.52

1.02 (3.71%)

PKI

PerkinElmer

$85.87

2.965 (3.58%)

ALNY

Alnylam

$78.02

(0.00%)

CVS

CVS Health

$80.33

0.78 (0.98%)

CBAY

CymaBay

$9.12

0.4 (4.59%)

CNC

Centene

$140.84

4.76 (3.50%)

TOCA

Tocagen

$12.09

0.56 (4.86%)

AMGN

Amgen

$201.43

4.25 (2.16%)

NERV

Minerva

$8.27

0.35 (4.42%)

TBIO

Translate Bio

$7.37

0.69 (10.33%)

RCUS

Arcus Biosciences

$11.55

0.64 (5.87%)

TXMD

TherapeuticsMD

$5.08

0.22 (4.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 29

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 05

    Dec

  • 12

    Dec

  • 14

    Dec

  • 20

    Dec

  • 18

    Feb

  • 30

    Jun

VYGR

Voyager Therapeutics

$12.04

0.2 (1.69%)

, JAZZ

Jazz Pharmaceuticals

$151.06

1.11 (0.74%)

16:33
11/26/18
11/26
16:33
11/26/18
16:33
Conference/Events
Evercore ISI to hold a conference »

Evercore ISI HEALTHConx…

VYGR

Voyager Therapeutics

$12.04

0.2 (1.69%)

JAZZ

Jazz Pharmaceuticals

$151.06

1.11 (0.74%)

ALXN

Alexion

$119.02

0.94 (0.80%)

IMGN

ImmunoGen

$5.73

0.23 (4.18%)

DOVA

Dova Pharmaceuticals

$15.05

-0.2 (-1.31%)

PRQR

ProQR Therapeutics

$19.11

-0.39 (-2.00%)

HRTX

Heron Therapeutics

$25.96

-0.065 (-0.25%)

BOLD

Audentes Therapeutics

$24.41

0.5 (2.09%)

CDNA

CareDx

$27.73

0.43 (1.58%)

PKI

PerkinElmer

$82.84

1.15 (1.41%)

ALNY

Alnylam

$78.49

5 (6.80%)

CVS

CVS Health

$77.83

2.3451 (3.11%)

CBAY

CymaBay

$9.00

-0.31 (-3.33%)

CNC

Centene

$138.46

2.23 (1.64%)

TOCA

Tocagen

$11.65

0.28 (2.46%)

AMGN

Amgen

$194.31

2.06 (1.07%)

NERV

Minerva

$8.67

-0.16 (-1.81%)

TBIO

Translate Bio

$6.86

-0.09 (-1.30%)

RCUS

Arcus Biosciences

$11.24

-0.37 (-3.19%)

TXMD

TherapeuticsMD

$4.85

-0.05 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 29

    Nov

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 05

    Dec

  • 12

    Dec

  • 14

    Dec

  • 20

    Dec

  • 18

    Feb

  • 30

    Jun

Over a month ago
PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

, ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

07:52
11/15/18
11/15
07:52
11/15/18
07:52
Initiation
ProQR Therapeutics, Spark Therapeutics initiated at Citi »

ProQR Therapeutics…

PRQR

ProQR Therapeutics

$17.82

-0.84 (-4.50%)

ONCE

Spark Therapeutics

$40.93

-1.81 (-4.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVID

Avid

$5.79

0.19 (3.39%)

, PRQR

ProQR Therapeutics

$19.00

0.34 (1.82%)

10:12
11/14/18
11/14
10:12
11/14/18
10:12
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

AVID

Avid

$5.79

0.19 (3.39%)

PRQR

ProQR Therapeutics

$19.00

0.34 (1.82%)

GWPH

GW Pharmaceuticals

$132.50

0.37 (0.28%)

ETRN

Equitrans Midstream

$21.73

0.55 (2.60%)

ZGEN

Zymogenetics

$0.00

(0.00%)

AGN

Allergan

$163.54

0.905 (0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 27

    Nov

PRQR

ProQR Therapeutics

$18.66

0.04 (0.21%)

07:13
11/14/18
11/14
07:13
11/14/18
07:13
Initiation
ProQR Therapeutics initiated at Cantor Fitzgerald »

Cantor starts ProQR with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$18.70

0.08 (0.43%)

16:07
11/13/18
11/13
16:07
11/13/18
16:07
Initiation
ProQR Therapeutics initiated at Cantor Fitzgerald »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.